Cargando…
Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study
BACKGROUND: Contrast-induced nephropathy (CIN) is one of the common hospital-acquired acute renal failures. The purpose of this study was to investigate whether Coenzyme Q10 (CoQ10) and trimetazidine (TMZ) can prevent the occurrence of CIN after elective cardiac catheterization in patients with coro...
Autores principales: | Chen, Fei, Liu, Fan, Lu, Jingchao, Yang, Xiuchun, Xiao, Bing, Jin, Yaqiong, Zhang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960150/ https://www.ncbi.nlm.nih.gov/pubmed/29776437 http://dx.doi.org/10.1186/s40001-018-0320-2 |
Ejemplares similares
-
Protective effects of trimetazidine and coenzyme Q10 on cisplatin-induced cardiotoxicity by alleviating oxidative stress and mitochondrial dysfunction
por: Zhao, Li
Publicado: (2019) -
Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study
por: Chen, Fei, et al.
Publicado: (2023) -
Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency
por: Ye, Ziliang, et al.
Publicado: (2017) -
Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
por: Galal, Haitham, et al.
Publicado: (2020) -
The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale
por: Mujtaba, Alhasan, et al.
Publicado: (2018)